What amount sold does CryptoMedix, Inc. report in Form D filings?

The latest linked filings report $277K sold across 1 identified offering(s). 0 unlinked amendment(s) are excluded; 0 offering(s) have no reported amount sold. This is not verified lifetime funding or money raised during a specific period.

When was CryptoMedix, Inc.'s most recent SEC filing?

CryptoMedix, Inc.'s most recent Form D filing was on 2016-06-08.

How many investors does CryptoMedix, Inc. have?

The most recent Form D filing lists 7 investor(s).

CryptoMedix, Inc.

CIK: 0001663510·Biotechnology·HARPSWELL, ME·Corporation·Founded 2013

Reported Sold

$276,500

Total Filings

Identified Offerings

Last Filed

Jun 8, 2016

Employees

—

Reported sold uses the latest linked filing for each identified offering; it is not verified lifetime funding. SPV filings are shown separately.

About

Company in Biotechnology industry

SEC EDGAR

Offering filing timeline

Jun 8, 2016Form D/A — Amendment

Reported sold: $276,500 · Target: $500,000

Rule 506(b)·7 investors

Changed: Reported amount sold, Offering target, Reported investors

Jan 19, 2016Form D — New notice

Reported sold: $0 · Target: $100,000

Rule 506(b)·0 investors

Fundraising Profile

Exemptions

Rule 506(b)

Investors in latest filing

Revenue Range

Decline to Disclose

Reported commissions across identified offerings

Amendment Rate

50%

Latest reported sold across 1 identified offering

$276,500

Uses the latest linked filing for each offering. This is not a measure of money raised in the last year or verified lifetime funding.

Key People

Bernd Seizinger

Related Person

Appears on 2 filings

Janet Yancey-Wrona

Related Person

Appears on 2 filings

Bob Davis

Related Person

Appears on 2 filings

Bob Suva

Related Person

Appears on 2 filings

Leonard Liebes

Related Person

Appears on 2 filings

Filing History

Date	Type	Offering target	Reported sold	Investors
Jun 8, 2016	Amendment	$500,000	$276,500	7
Jan 19, 2016	New	$100,000	$0	0

Filing History

Amendment insights

Loading amendment history…

Comparable issuers

Matched on reported industry and issuer type, then ranked by business location, offering target, and recency. These are filing comparables, not verified business competitors.

Opus KSD, Inc.

Biotechnology

Offering target: $680,801

Filed Oct 1, 2026